Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine/Cisplatin vs S-1/Cisplatin in Advanced Biliary Cancer
NCT01096745Phase 2Terminated
- Sponsor
- Gyeongsang National University Hospital
- Start
- Jul 2010
- Primary completion
- Mar 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tegafur in biliary tract cancer (BTC), sponsored by Gyeongsang National University Hospital. Started Jul 2010; status: terminated.
02
Drugs
tegafur
03
Conditions
biliary tract cancer (BTC)
Beyond the preview
Go deeper on NCT01096745.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01096745.